PDCD1 and melanoma: It was revealed that the dual blockades of PD-1 and CTLA-4, in contrast to individual inhibition, significantly enhanced the CD8+ T cells/Tregs and CD8+ T cells/MDSCs ratios within the tumor in mice with melanoma.